P2X7 purinoceptor antagonists (AstraZeneca)
N/A
Report date: 2025/01/26 16:39:46
NME
Base Information
Drug NameP2X7 purinoceptor antagonists (AstraZeneca)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Of London
Inactive CompaniesAstrazeneca Plc
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A